Gossamer Bio

+$0.25 (+2.86%) Today
-$0.10 (-1.11%) As of 8:58 PM UTC after-hours

Why Robinhood?

You can buy or sell Gossamer Bio and other stocks, options, and ETFs commission-free!

About GOSS

Gossamer Bio, Inc. engages in discovering, acquiring, developing, and commercializing therapeutics in the disease areas of immunology, inflammation, and oncology. Its primary product candidate, GB001, is intended for the treatment of moderate-to-severe eosinophilic asthma and other allergic conditions.

CEO
Faheem Hasnain
Employees
195
Headquarters
San Diego, California
Founded
2015

GOSS Key Statistics

Market Cap
668.99M
Price-Earnings Ratio
—
Dividend Yield
—
Average Volume
609.34K
High Today
$9.06
Low Today
$8.65
Open Price
$8.75
Volume
461.10K
52 Week High
$15.42
52 Week Low
$7.63

GOSS Earnings

-$1.00
-$0.67
-$0.33
$0.00
Q3 FY19
Q4 FY19
Q1 FY20
Q2 FY20
Q3 FY20
Q4 FY20
Q1 FY21
Estimated
-$0.75 per share
Actual
-$0.78 per share

You May Also Like

ASET
All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, a registered broker-dealer and Member SIPC. Full disclosure